Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NeoGenomics Inc | NEO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
14.03 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 11.03 - 21.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 14.03 | USD |
NeoGenomics (NEO) Options Flow Summary
NeoGenomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.79B | 127.61M | - | 591.64M | -87.97M | -0.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NeoGenomics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NEO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 13.70 | 14.47 | 13.34 | 13.77 | 774,439 | 0.33 | 2.41% |
1 Month | 15.14 | 15.91 | 13.34 | 14.38 | 661,558 | -1.11 | -7.33% |
3 Months | 15.17 | 17.49 | 13.34 | 15.15 | 895,028 | -1.14 | -7.51% |
6 Months | 14.59 | 21.22 | 13.33 | 16.32 | 976,883 | -0.56 | -3.84% |
1 Year | 15.30 | 21.22 | 11.03 | 15.84 | 932,470 | -1.27 | -8.30% |
3 Years | 50.93 | 54.74 | 6.00 | 18.18 | 1,175,389 | -36.90 | -72.45% |
5 Years | 20.02 | 61.57 | 6.00 | 23.17 | 1,046,779 | -5.99 | -29.92% |
NeoGenomics Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. |